---
title: "Bristol Myers Squibb's second-quarter revenue was $12.27 billion, estimated at $11.38 billion"
description: "Bristol Myers Squibb's second-quarter revenue was $12.27 billion, estimated at $11.38 billion"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/250973734.md"
published_at: "2025-07-31T10:59:43.000Z"
---

# Bristol Myers Squibb's second-quarter revenue was $12.27 billion, estimated at $11.38 billion

Bristol Myers Squibb's second-quarter revenue was $12.27 billion, estimated at $11.38 billion

### Related Stocks

- [BMY.US - Bristol Myers Squibb](https://longbridge.com/en/quote/BMY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Key facts: Bristol Myers Squibb's Opdivo gets FDA priority review; Dividend raised to $0.63; Hematology pipeline enhancements underway | Bristol Myers Squibb's Opdivo has received FDA priority review for expanded approval in treating untreated stage III or  | [Link](https://longbridge.com/en/news/269425451.md) |
| Herbalife (HLF) To Report Earnings Tomorrow: Here Is What To Expect | Herbalife will report its earnings results tomorrow, with analysts expecting a revenue growth of 2.5% year-on-year to $1 | [Link](https://longbridge.com/en/news/276090591.md) |
| Salesforce CEO Marc Benioff's ICE joke was delivered at a difficult time for his company | Salesforce CEO Marc Benioff's ICE joke was delivered at a difficult time for his company | [Link](https://longbridge.com/en/news/275896154.md) |
| AB Inbev CFO Fernando Tennenbaum: 2026 will hopefully be a more normal year on costs, we see further opportunities to expand margin | AB Inbev CFO Fernando Tennenbaum: 2026 will hopefully be a more normal year on costs, we see further opportunities to ex | [Link](https://longbridge.com/en/news/275819045.md) |
| Behind the Scenes of Albemarle's Latest Options Trends | Deep-pocketed investors are showing a bullish trend towards Albemarle (NYSE:ALB), with 28 significant options activities | [Link](https://longbridge.com/en/news/275787820.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.